Ranedis Pharmaceuticals
Healthtech
Overview
At RaNeDis Pharmaceuticals we are focused on the treatment and management of rare and neglected diseases. RaNeDis Pharmaceuticals is a development stage pharmaceutical company engaged in the development of a novel formulation of an HDAC inhibitor with enhanced brain exposure for the treatment of rare genetic, metabolic diseases.
RaNeDis Pharmaceuticals’ technology was licensed from the University of Notre Dame.
Founder(s)
William Claypool